Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough.
Ran DongXianghuai XuLi YuHongmei DingJing PanYiming YuCuiqin ShiQiang ChenMengru ZhangHanjing LvZhongmin QiuPublished in: Alimentary pharmacology & therapeutics (2019)
Gabapentin and baclofen have similar therapeutic efficacy for suspected refractory gastro-oesophageal reflux-induced chronic cough. However, gabapentin may be preferable because of fewer side effects. Trial Register: http://www.chictr.org/; No.: ChiCTR-ONC-13003066.